Orange County, California Dangerous Drug: Fosamax Again Linked to Eye Conditions

December 31, 1969

According to Canadian researchers, bisphosphonates, of which Fosamax is one, may up the risk of the eye conditions scleritis and uveitis. These findings can be found in the Canadian Medical Association Journal.

Over 900,000 British Columbia residents who went to see eye doctors between 2000 and 2007 were evaluated for this study. Patients taking prescription bisphosphonates and those not on these medications were compared. Per the study, for every 1,100 patients who had just started taking an osteoporosis medication, there was one more case of uveitis compared to the people who were taking this type of drug. For every 370 bisphosphonate users, again compared to the general population, there was one additional report of scleritis.

Scleritis causes eye irritation and swelling. Uveitis creates inner eye inflammation. Although steroid eye drops can usually treat both conditions, in some cases, permanent eye damage may result.

Fosamax already has been linked to serious bone conditions, including osteonecrosis of the jaw, atypical stress fractures, thigh fractures, and severely suppressed bone turnover. Numerous Fosamax lawsuits against drug maker Merck has since followed. Other researchers have found a connection between bisphosphonates and eye injuries in the past. These latest findings appear to confirm this.

"Our Anaheim Fosamax injury lawyers represent women who have suffered serious injuries because they were prescribed the drug," said Orange County, California Dangerous Drug Attorney Vincent Howard.

For many people as they grow older, bone brittleness and deterioration are already serious issues of concern. Osteoporosis, which involves the loss and thinning of bone tissue and density is a bone disease that affects one out of every five women in the 50 or older age group. This makes it easier for them to break a bone or fracture a hip.

Bone pain, height loss, neck pain, lower back pain, and poor posture are some of the signs of osteoporosis. Fosamax is prescribed to treat this condition and one reason why it is even more astounding to see how taking this medication or or alendronate, its generic version, appears to have the opposite effect intended, meaning that in some cases, a woman's bones become weaker rather than stronger.

"It is unacceptable for any prescription drug or over-the-counter medication to cause a patient to suffer debilitating health issues, other serious injuries, or death," said Anaheim Products Liability Lawyer Vincent Howard. "Negligent drug manufacturer should be held liable."

Also, if taking bisphosphonates helps more than hurts then this raises serious issues as to why a drug that weakens the bones is being marketed and prescribed as a medication.

Studies link drugs to eye ailments, The Globe and Mail, April 5, 2012

Canadian Medical Association Journal

Fosamax Type Osteoporosis Drugs Noted to Cause Serious Eye Problems, Mercola, April 9, 2003


More Blog Posts:
Food and Drug Administration Advisory Panel is Worried about the Number of Injuries Linked to Fosamax, California Injury Lawyers, September 16, 2011

FDA Advisory Panel to Review Risks Associated with Taking Fosamax, California Injury Lawyers, September 8, 2011

Does Fosamax Increase the Risk of Esophageal Cancer?, California Injury Lawyers, July 31, 2011

At Howard Law PC, we are dedicated to helping our clients injured by Fosamax and other meds to recover their personal injury compensation. We also represent patients injured by other medications. Contact Anaheim Personal Injury Attorney Vincent Howard today. Your initial, no obligation consultation is free.